Filed: 11/14/2023ACC: 0000919574-23-006304
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $26.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$26.32M
Total AUM (reported)
10.60M
Total Shares
Allocation by class
COM$23.72M90.1%
COM NEW$2.61M9.9%
Portfolio Concentration
Top 3$24.76M94.1%
4–10$1.56M5.9%
Top 3 weight
94.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.60M
Sole
Full voting authority
10.60M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings9
Rows:
SAVARA INC
SOLEShares3.31M
TypeSH
Market value$12.53M
47.59%
Sole
3.31M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares5.64M
TypeSH
Market value$10.49M
39.87%
Sole
5.64M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.32M
TypeSH
Market value$1.74M
6.61%
Sole
1.32M
Shared
0.00
None
0.00
MOLECULAR TEMPLATES INC
SOLEShares136.87K
TypeSH
Market value$865.0K
3.29%
Sole
136.87K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares12.47K
TypeSH
Market value$265.7K
1.01%
Sole
12.47K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares86.77K
TypeSH
Market value$170.9K
0.65%
Sole
86.77K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares19.47K
TypeSH
Market value$133.4K
0.51%
Sole
19.47K
Shared
0.00
None
0.00
ALLAKOS INC
SOLEShares49.33K
TypeSH
Market value$112.0K
0.43%
Sole
49.33K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares21.81K
TypeSH
Market value$14.5K
0.05%
Sole
21.81K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SAVARA INCSOLE | COM | 3.31M | SH | $12.53M 47.59% | 3.31M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 5.64M | SH | $10.49M 39.87% | 5.64M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.32M | SH | $1.74M 6.61% | 1.32M | 0.00 | 0.00 |
MOLECULAR TEMPLATES INCSOLE | COM NEW | 136.87K | SH | $865.0K 3.29% | 136.87K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 12.47K | SH | $265.7K 1.01% | 12.47K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 86.77K | SH | $170.9K 0.65% | 86.77K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 19.47K | SH | $133.4K 0.51% | 19.47K | 0.00 | 0.00 |
ALLAKOS INCSOLE | COM | 49.33K | SH | $112.0K 0.43% | 49.33K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 21.81K | SH | $14.5K 0.05% | 21.81K | 0.00 | 0.00 |